GDP | MHRA

Total Records 1691 to 1700 of 2826

GDP Search Results
Certificate Number	Site Details	Country	Inspection Date
UK WDA(H) 32357 Insp GDP 32357/18792945-0001	IMMOBILIER FRANCE LIMITED, UNIT 4 STANLEY COURT, SHEARWAY BUSINESS PARK, SHEARWAY ROAD, FOLKESTONE, CT19 4FJ, UNITED KINGDOM	UNITED KINGDOM	14/06/2019
UK WDA(H) 27776 Insp GMP/GDP 14756/5569-0013	HELIOS HOMOEOPATHY LIMITED, 89-97 CAMDEN ROAD, TUNBRIDGE WELLS, TN1 2QR, UNITED KINGDOM	UNITED KINGDOM	12/06/2019
UK WDA(H) 35808 Insp GDP 35808/12388157-0002	PHARMACY CARE PLUS LIMITED T\A WALTON PHARMACY, 46 ECCLESHALL ROAD, STONE, ST15 0HN, UNITED KINGDOM	UNITED KINGDOM	11/06/2019
UK WDA(H) 35808 Insp GDP 35808/12388129-0002	PHARMACY CARE PLUS LTD T\A BIRCHILL & WATSON PHARMACY, HIGH STREET, 16 HIGH STREET, STONE, ST15 8AW, UNITED KINGDOM	UNITED KINGDOM	11/06/2019
UK WDA(H) 20920 Insp GDP 20920/5359246-0003	GENERAL PHARMACEUTICALS LIMITED, CHURSTON HOUSE, PORTSMOUTH ROAD, ESHER, KT10 9AD, UNITED KINGDOM	UNITED KINGDOM	07/06/2019
UK API 398 Insp GMP/GDP 398/15148-0016	STD PHARMACEUTICAL PRODUCTS LIMITED, PLOUGH LANE, HEREFORD, HR4 0EL, UNITED KINGDOM	UNITED KINGDOM	06/06/2019
UK WDA(H) 398 Insp GMP/GDP 398/15148-0015	STD PHARMACEUTICAL PRODUCTS LIMITED, PLOUGH LANE, HEREFORD, HR4 0EL, UNITED KINGDOM	UNITED KINGDOM	06/06/2019
UK WDA(H) 40147 Insp GDP 40147/22318-0032	PHARMPACT LIMITED \ ENNOGEN HEALTHCARE LIMITED \ ENNOGEN PHARMA LIMITED, UNIT G2, G3 & G4, RIVERSIDE INDUSTRIAL ESTATE, RIVERSIDE WAY, DARTFORD, DA1 5BS, UNITED KINGDOM	UNITED KINGDOM	05/06/2019
UK API 48180 Insp GDP 48180/16864192-0001	SWANNELLS TRANSPORT LIMITED, 14 WARBOYS AIRFIELD INDUSTRIAL ESTATE, HUNTINGDON, PE28 2SH, UNITED KINGDOM	UNITED KINGDOM	31/05/2019
UK WDA(H) 41807 Insp GDP 41807/12538088-0002	WALSALL HEALTHCARE NHS TRUST, WALSALL MANOR HOSPITAL, DEPT PHARMACY (ROUTE 239), MOAT ROAD, WALSALL, WS2 9PS, UNITED KINGDOM	UNITED KINGDOM	30/05/2019

Due to the restrictions caused by COVID-19, the period of validity GMP and GDP certificates issued by MHRA is automatically extended until the end of 2024, except where clarifying remarks in the document state otherwise. Manufacturers, importers and distributors must continue to comply with GMP/GDP and all other legal obligations. On-site inspections are now being conducted and scheduling of these inspections may be independent of the extended validity period stated above. MHRA reserve the right to perform risk based supervision of sites by either on-site inspections or distant assessments and, based on the outcome, may continue to issue, withdraw or restrict GMP and GDP certificates, as appropriate.

Download XLSX